nodes	percent_of_prediction	percent_of_DWPC	metapath
Telithromycin—CYP3A4—Thiotepa—urinary bladder cancer	0.0974	0.279	CbGbCtD
Telithromycin—CYP3A5—Etoposide—urinary bladder cancer	0.0677	0.194	CbGbCtD
Telithromycin—CYP1A2—Fluorouracil—urinary bladder cancer	0.0604	0.173	CbGbCtD
Telithromycin—CYP1A2—Etoposide—urinary bladder cancer	0.0504	0.145	CbGbCtD
Telithromycin—CYP2D6—Doxorubicin—urinary bladder cancer	0.0283	0.0812	CbGbCtD
Telithromycin—CYP3A4—Etoposide—urinary bladder cancer	0.0264	0.0757	CbGbCtD
Telithromycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.018	0.0517	CbGbCtD
Telithromycin—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.000923	0.00582	CbGpPWpGaD
Telithromycin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000922	0.00581	CbGpPWpGaD
Telithromycin—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000916	0.00577	CbGpPWpGaD
Telithromycin—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000911	0.00574	CbGpPWpGaD
Telithromycin—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.00087	0.00548	CbGpPWpGaD
Telithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000862	0.00543	CbGpPWpGaD
Telithromycin—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.000844	0.00532	CbGpPWpGaD
Telithromycin—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000833	0.00525	CbGpPWpGaD
Telithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000821	0.00517	CbGpPWpGaD
Telithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00081	0.0051	CbGpPWpGaD
Telithromycin—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.00076	0.00479	CbGpPWpGaD
Telithromycin—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00075	0.00472	CbGpPWpGaD
Telithromycin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000707	0.00445	CbGpPWpGaD
Telithromycin—CYP3A7—Biological oxidations—NAT2—urinary bladder cancer	0.0007	0.00441	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.0007	0.00441	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000693	0.00436	CbGpPWpGaD
Telithromycin—CYP3A7—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00069	0.00435	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000683	0.0043	CbGpPWpGaD
Telithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000665	0.00419	CbGpPWpGaD
Telithromycin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000663	0.00418	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000657	0.00414	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000657	0.00414	CbGpPWpGaD
Telithromycin—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000655	0.00412	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000648	0.00408	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.0006	0.00378	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000592	0.00373	CbGpPWpGaD
Telithromycin—Infestation—Methotrexate—urinary bladder cancer	0.00059	0.0012	CcSEcCtD
Telithromycin—Hypotension—Etoposide—urinary bladder cancer	0.000587	0.00119	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000587	0.0037	CbGpPWpGaD
Telithromycin—Gastritis—Doxorubicin—urinary bladder cancer	0.000587	0.00119	CcSEcCtD
Telithromycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000585	0.00119	CcSEcCtD
Telithromycin—Neutropenia—Epirubicin—urinary bladder cancer	0.000579	0.00118	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000579	0.00365	CbGpPWpGaD
Telithromycin—Dizziness—Thiotepa—urinary bladder cancer	0.000578	0.00117	CcSEcCtD
Telithromycin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000577	0.00117	CcSEcCtD
Telithromycin—Stomatitis—Methotrexate—urinary bladder cancer	0.000575	0.00117	CcSEcCtD
Telithromycin—Urticaria—Fluorouracil—urinary bladder cancer	0.000575	0.00117	CcSEcCtD
Telithromycin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000567	0.00115	CcSEcCtD
Telithromycin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000565	0.00115	CcSEcCtD
Telithromycin—Paraesthesia—Etoposide—urinary bladder cancer	0.000564	0.00115	CcSEcCtD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000564	0.00355	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000564	0.00355	CbGpPWpGaD
Telithromycin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000562	0.00114	CcSEcCtD
Telithromycin—CYP3A7—Biological oxidations—HPGDS—urinary bladder cancer	0.000559	0.00352	CbGpPWpGaD
Telithromycin—Somnolence—Etoposide—urinary bladder cancer	0.000558	0.00113	CcSEcCtD
Telithromycin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000558	0.00113	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000556	0.0035	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000556	0.0035	CbGpPWpGaD
Telithromycin—Vomiting—Thiotepa—urinary bladder cancer	0.000556	0.00113	CcSEcCtD
Telithromycin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000552	0.00112	CcSEcCtD
Telithromycin—Infestation—Epirubicin—urinary bladder cancer	0.000552	0.00112	CcSEcCtD
Telithromycin—Rash—Thiotepa—urinary bladder cancer	0.000551	0.00112	CcSEcCtD
Telithromycin—Dermatitis—Thiotepa—urinary bladder cancer	0.000551	0.00112	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000549	0.00346	CbGpPWpGaD
Telithromycin—Headache—Thiotepa—urinary bladder cancer	0.000548	0.00111	CcSEcCtD
Telithromycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000547	0.00111	CcSEcCtD
Telithromycin—Decreased appetite—Etoposide—urinary bladder cancer	0.000546	0.00111	CcSEcCtD
Telithromycin—CYP3A7—Biological oxidations—GSTT1—urinary bladder cancer	0.000543	0.00342	CbGpPWpGaD
Telithromycin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000542	0.0011	CcSEcCtD
Telithromycin—Fatigue—Etoposide—urinary bladder cancer	0.000542	0.0011	CcSEcCtD
Telithromycin—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000541	0.00341	CbGpPWpGaD
Telithromycin—Jaundice—Epirubicin—urinary bladder cancer	0.000538	0.00109	CcSEcCtD
Telithromycin—Stomatitis—Epirubicin—urinary bladder cancer	0.000538	0.00109	CcSEcCtD
Telithromycin—Constipation—Etoposide—urinary bladder cancer	0.000537	0.00109	CcSEcCtD
Telithromycin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000536	0.00109	CcSEcCtD
Telithromycin—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000533	0.00336	CbGpPWpGaD
Telithromycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000533	0.00108	CcSEcCtD
Telithromycin—Hepatitis—Methotrexate—urinary bladder cancer	0.00053	0.00108	CcSEcCtD
Telithromycin—Asthenia—Gemcitabine—urinary bladder cancer	0.000528	0.00107	CcSEcCtD
Telithromycin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000522	0.00106	CcSEcCtD
Telithromycin—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000521	0.00328	CbGpPWpGaD
Telithromycin—Pruritus—Gemcitabine—urinary bladder cancer	0.00052	0.00106	CcSEcCtD
Telithromycin—Nausea—Thiotepa—urinary bladder cancer	0.000519	0.00105	CcSEcCtD
Telithromycin—Sinusitis—Epirubicin—urinary bladder cancer	0.000518	0.00105	CcSEcCtD
Telithromycin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000518	0.00105	CcSEcCtD
Telithromycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000514	0.00104	CcSEcCtD
Telithromycin—Pruritus—Fluorouracil—urinary bladder cancer	0.000512	0.00104	CcSEcCtD
Telithromycin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000511	0.00104	CcSEcCtD
Telithromycin—Infestation—Doxorubicin—urinary bladder cancer	0.000511	0.00104	CcSEcCtD
Telithromycin—Visual impairment—Methotrexate—urinary bladder cancer	0.00051	0.00104	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000509	0.0032	CbGpPWpGaD
Telithromycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000506	0.00103	CcSEcCtD
Telithromycin—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.000506	0.00319	CbGpPWpGaD
Telithromycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000505	0.00103	CcSEcCtD
Telithromycin—Bradycardia—Epirubicin—urinary bladder cancer	0.000505	0.00102	CcSEcCtD
Telithromycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000503	0.00102	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000502	0.00316	CbGpPWpGaD
Telithromycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000501	0.00102	CcSEcCtD
Telithromycin—Urticaria—Etoposide—urinary bladder cancer	0.000499	0.00101	CcSEcCtD
Telithromycin—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000499	0.00314	CbGpPWpGaD
Telithromycin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000498	0.00101	CcSEcCtD
Telithromycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000498	0.00101	CcSEcCtD
Telithromycin—Abdominal pain—Etoposide—urinary bladder cancer	0.000497	0.00101	CcSEcCtD
Telithromycin—Hepatitis—Epirubicin—urinary bladder cancer	0.000496	0.00101	CcSEcCtD
Telithromycin—Eye disorder—Methotrexate—urinary bladder cancer	0.000495	0.001	CcSEcCtD
Telithromycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000495	0.001	CcSEcCtD
Telithromycin—Asthenia—Cisplatin—urinary bladder cancer	0.000492	0.000999	CcSEcCtD
Telithromycin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000492	0.000998	CcSEcCtD
Telithromycin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000488	0.000991	CcSEcCtD
Telithromycin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000487	0.000989	CcSEcCtD
Telithromycin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000483	0.000981	CcSEcCtD
Telithromycin—Angiopathy—Methotrexate—urinary bladder cancer	0.000481	0.000975	CcSEcCtD
Telithromycin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000479	0.000973	CcSEcCtD
Telithromycin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000478	0.000971	CcSEcCtD
Telithromycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000478	0.000971	CcSEcCtD
Telithromycin—Visual impairment—Epirubicin—urinary bladder cancer	0.000478	0.00097	CcSEcCtD
Telithromycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000469	0.000952	CcSEcCtD
Telithromycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000469	0.000951	CcSEcCtD
Telithromycin—Vomiting—Gemcitabine—urinary bladder cancer	0.000468	0.000949	CcSEcCtD
Telithromycin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000467	0.000948	CcSEcCtD
Telithromycin—Mental disorder—Methotrexate—urinary bladder cancer	0.000464	0.000942	CcSEcCtD
Telithromycin—Rash—Gemcitabine—urinary bladder cancer	0.000464	0.000942	CcSEcCtD
Telithromycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000463	0.000941	CcSEcCtD
Telithromycin—Eye disorder—Epirubicin—urinary bladder cancer	0.000463	0.00094	CcSEcCtD
Telithromycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000463	0.00094	CcSEcCtD
Telithromycin—Malnutrition—Methotrexate—urinary bladder cancer	0.000461	0.000936	CcSEcCtD
Telithromycin—Headache—Gemcitabine—urinary bladder cancer	0.000461	0.000936	CcSEcCtD
Telithromycin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00046	0.000934	CcSEcCtD
Telithromycin—Flushing—Epirubicin—urinary bladder cancer	0.00046	0.000934	CcSEcCtD
Telithromycin—Vomiting—Fluorouracil—urinary bladder cancer	0.00046	0.000934	CcSEcCtD
Telithromycin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000459	0.000931	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000458	0.00289	CbGpPWpGaD
Telithromycin—Rash—Fluorouracil—urinary bladder cancer	0.000456	0.000926	CcSEcCtD
Telithromycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000456	0.000925	CcSEcCtD
Telithromycin—Headache—Fluorouracil—urinary bladder cancer	0.000453	0.00092	CcSEcCtD
Telithromycin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000453	0.00285	CbGpPWpGaD
Telithromycin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000452	0.000917	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000452	0.00285	CbGpPWpGaD
Telithromycin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000451	0.000916	CcSEcCtD
Telithromycin—Asthenia—Etoposide—urinary bladder cancer	0.000451	0.000915	CcSEcCtD
Telithromycin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000451	0.000915	CcSEcCtD
Telithromycin—Angiopathy—Epirubicin—urinary bladder cancer	0.00045	0.000913	CcSEcCtD
Telithromycin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000448	0.000909	CcSEcCtD
Telithromycin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000447	0.00281	CbGpPWpGaD
Telithromycin—Back pain—Methotrexate—urinary bladder cancer	0.000446	0.000905	CcSEcCtD
Telithromycin—Pruritus—Etoposide—urinary bladder cancer	0.000444	0.000902	CcSEcCtD
Telithromycin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000443	0.000899	CcSEcCtD
Telithromycin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000442	0.000897	CcSEcCtD
Telithromycin—Nausea—Gemcitabine—urinary bladder cancer	0.000437	0.000887	CcSEcCtD
Telithromycin—Vomiting—Cisplatin—urinary bladder cancer	0.000436	0.000885	CcSEcCtD
Telithromycin—Vision blurred—Methotrexate—urinary bladder cancer	0.000435	0.000882	CcSEcCtD
Telithromycin—Mental disorder—Epirubicin—urinary bladder cancer	0.000434	0.000881	CcSEcCtD
Telithromycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000434	0.00088	CcSEcCtD
Telithromycin—Rash—Cisplatin—urinary bladder cancer	0.000432	0.000878	CcSEcCtD
Telithromycin—Dermatitis—Cisplatin—urinary bladder cancer	0.000432	0.000877	CcSEcCtD
Telithromycin—Malnutrition—Epirubicin—urinary bladder cancer	0.000431	0.000876	CcSEcCtD
Telithromycin—Diarrhoea—Etoposide—urinary bladder cancer	0.00043	0.000872	CcSEcCtD
Telithromycin—Nausea—Fluorouracil—urinary bladder cancer	0.00043	0.000872	CcSEcCtD
Telithromycin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000429	0.0027	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000429	0.0027	CbGpPWpGaD
Telithromycin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000429	0.00087	CcSEcCtD
Telithromycin—Anaemia—Methotrexate—urinary bladder cancer	0.000426	0.000865	CcSEcCtD
Telithromycin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000426	0.000864	CcSEcCtD
Telithromycin—Flushing—Doxorubicin—urinary bladder cancer	0.000426	0.000864	CcSEcCtD
Telithromycin—Flatulence—Epirubicin—urinary bladder cancer	0.000425	0.000863	CcSEcCtD
Telithromycin—Tension—Epirubicin—urinary bladder cancer	0.000423	0.000859	CcSEcCtD
Telithromycin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000423	0.00267	CbGpPWpGaD
Telithromycin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000423	0.000858	CcSEcCtD
Telithromycin—Nervousness—Epirubicin—urinary bladder cancer	0.000419	0.000851	CcSEcCtD
Telithromycin—Back pain—Epirubicin—urinary bladder cancer	0.000417	0.000847	CcSEcCtD
Telithromycin—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000416	0.00262	CbGpPWpGaD
Telithromycin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000416	0.000845	CcSEcCtD
Telithromycin—Dizziness—Etoposide—urinary bladder cancer	0.000415	0.000843	CcSEcCtD
Telithromycin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000415	0.000842	CcSEcCtD
Telithromycin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000414	0.000841	CcSEcCtD
Telithromycin—Vertigo—Methotrexate—urinary bladder cancer	0.000414	0.000841	CcSEcCtD
Telithromycin—Leukopenia—Methotrexate—urinary bladder cancer	0.000413	0.000838	CcSEcCtD
Telithromycin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00041	0.000832	CcSEcCtD
Telithromycin—Nausea—Cisplatin—urinary bladder cancer	0.000407	0.000827	CcSEcCtD
Telithromycin—Vision blurred—Epirubicin—urinary bladder cancer	0.000407	0.000825	CcSEcCtD
Telithromycin—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000404	0.00255	CbGpPWpGaD
Telithromycin—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000404	0.00254	CbGpPWpGaD
Telithromycin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000402	0.000816	CcSEcCtD
Telithromycin—Vomiting—Etoposide—urinary bladder cancer	0.000399	0.000811	CcSEcCtD
Telithromycin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000399	0.00081	CcSEcCtD
Telithromycin—Anaemia—Epirubicin—urinary bladder cancer	0.000399	0.00081	CcSEcCtD
Telithromycin—Rash—Etoposide—urinary bladder cancer	0.000396	0.000804	CcSEcCtD
Telithromycin—Dermatitis—Etoposide—urinary bladder cancer	0.000396	0.000803	CcSEcCtD
Telithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000395	0.00249	CbGpPWpGaD
Telithromycin—Headache—Etoposide—urinary bladder cancer	0.000394	0.000799	CcSEcCtD
Telithromycin—Flatulence—Doxorubicin—urinary bladder cancer	0.000393	0.000799	CcSEcCtD
Telithromycin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000393	0.00247	CbGpPWpGaD
Telithromycin—Myalgia—Methotrexate—urinary bladder cancer	0.000393	0.000797	CcSEcCtD
Telithromycin—Arthralgia—Methotrexate—urinary bladder cancer	0.000393	0.000797	CcSEcCtD
Telithromycin—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000392	0.00247	CbGpPWpGaD
Telithromycin—Tension—Doxorubicin—urinary bladder cancer	0.000392	0.000795	CcSEcCtD
Telithromycin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000391	0.000794	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00039	0.000791	CcSEcCtD
Telithromycin—Nervousness—Doxorubicin—urinary bladder cancer	0.000388	0.000787	CcSEcCtD
Telithromycin—Vertigo—Epirubicin—urinary bladder cancer	0.000388	0.000787	CcSEcCtD
Telithromycin—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000387	0.00244	CbGpPWpGaD
Telithromycin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000387	0.00244	CbGpPWpGaD
Telithromycin—Syncope—Epirubicin—urinary bladder cancer	0.000387	0.000785	CcSEcCtD
Telithromycin—Leukopenia—Epirubicin—urinary bladder cancer	0.000386	0.000784	CcSEcCtD
Telithromycin—Back pain—Doxorubicin—urinary bladder cancer	0.000386	0.000784	CcSEcCtD
Telithromycin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000384	0.000779	CcSEcCtD
Telithromycin—Palpitations—Epirubicin—urinary bladder cancer	0.000381	0.000774	CcSEcCtD
Telithromycin—Confusional state—Methotrexate—urinary bladder cancer	0.000379	0.00077	CcSEcCtD
Telithromycin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000379	0.00077	CcSEcCtD
Telithromycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000376	0.000764	CcSEcCtD
Telithromycin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000376	0.000764	CcSEcCtD
Telithromycin—CYP3A7—Biological oxidations—GSTP1—urinary bladder cancer	0.000376	0.00237	CbGpPWpGaD
Telithromycin—Nausea—Etoposide—urinary bladder cancer	0.000373	0.000757	CcSEcCtD
Telithromycin—CYP3A7—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000371	0.00234	CbGpPWpGaD
Telithromycin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000369	0.000749	CcSEcCtD
Telithromycin—Anaemia—Doxorubicin—urinary bladder cancer	0.000369	0.000749	CcSEcCtD
Telithromycin—Arthralgia—Epirubicin—urinary bladder cancer	0.000367	0.000746	CcSEcCtD
Telithromycin—Myalgia—Epirubicin—urinary bladder cancer	0.000367	0.000746	CcSEcCtD
Telithromycin—Anxiety—Epirubicin—urinary bladder cancer	0.000366	0.000743	CcSEcCtD
Telithromycin—Skin disorder—Methotrexate—urinary bladder cancer	0.000365	0.000742	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000365	0.000741	CcSEcCtD
Telithromycin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000364	0.000738	CcSEcCtD
Telithromycin—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.00036	0.00227	CbGpPWpGaD
Telithromycin—Dry mouth—Epirubicin—urinary bladder cancer	0.000359	0.000729	CcSEcCtD
Telithromycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000359	0.000728	CcSEcCtD
Telithromycin—Anorexia—Methotrexate—urinary bladder cancer	0.000359	0.000728	CcSEcCtD
Telithromycin—Syncope—Doxorubicin—urinary bladder cancer	0.000358	0.000727	CcSEcCtD
Telithromycin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000357	0.000725	CcSEcCtD
Telithromycin—Confusional state—Epirubicin—urinary bladder cancer	0.000355	0.000721	CcSEcCtD
Telithromycin—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000355	0.00224	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000353	0.00223	CbGpPWpGaD
Telithromycin—Palpitations—Doxorubicin—urinary bladder cancer	0.000353	0.000716	CcSEcCtD
Telithromycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000352	0.000715	CcSEcCtD
Telithromycin—Hypotension—Methotrexate—urinary bladder cancer	0.000352	0.000714	CcSEcCtD
Telithromycin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000351	0.000712	CcSEcCtD
Telithromycin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000349	0.0022	CbGpPWpGaD
Telithromycin—Shock—Epirubicin—urinary bladder cancer	0.000346	0.000703	CcSEcCtD
Telithromycin—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.000346	0.00218	CbGpPWpGaD
Telithromycin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000345	0.000701	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000343	0.000696	CcSEcCtD
Telithromycin—Skin disorder—Epirubicin—urinary bladder cancer	0.000342	0.000694	CcSEcCtD
Telithromycin—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000341	0.00215	CbGpPWpGaD
Telithromycin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00034	0.000691	CcSEcCtD
Telithromycin—Insomnia—Methotrexate—urinary bladder cancer	0.00034	0.000691	CcSEcCtD
Telithromycin—Myalgia—Doxorubicin—urinary bladder cancer	0.00034	0.00069	CcSEcCtD
Telithromycin—Arthralgia—Doxorubicin—urinary bladder cancer	0.00034	0.00069	CcSEcCtD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.00034	0.00214	CbGpPWpGaD
Telithromycin—Anxiety—Doxorubicin—urinary bladder cancer	0.000339	0.000688	CcSEcCtD
Telithromycin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000338	0.000686	CcSEcCtD
Telithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000338	0.000685	CcSEcCtD
Telithromycin—Anorexia—Epirubicin—urinary bladder cancer	0.000336	0.000681	CcSEcCtD
Telithromycin—Somnolence—Methotrexate—urinary bladder cancer	0.000335	0.000679	CcSEcCtD
Telithromycin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000332	0.000675	CcSEcCtD
Telithromycin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000331	0.000672	CcSEcCtD
Telithromycin—Hypotension—Epirubicin—urinary bladder cancer	0.000329	0.000668	CcSEcCtD
Telithromycin—Confusional state—Doxorubicin—urinary bladder cancer	0.000329	0.000667	CcSEcCtD
Telithromycin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000327	0.000664	CcSEcCtD
Telithromycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000326	0.000661	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000325	0.000659	CcSEcCtD
Telithromycin—Fatigue—Methotrexate—urinary bladder cancer	0.000324	0.000659	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000321	0.000651	CcSEcCtD
Telithromycin—Shock—Doxorubicin—urinary bladder cancer	0.000321	0.000651	CcSEcCtD
Telithromycin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00032	0.000649	CcSEcCtD
Telithromycin—Insomnia—Epirubicin—urinary bladder cancer	0.000318	0.000647	CcSEcCtD
Telithromycin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000316	0.000642	CcSEcCtD
Telithromycin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000316	0.000642	CcSEcCtD
Telithromycin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000315	0.000639	CcSEcCtD
Telithromycin—Somnolence—Epirubicin—urinary bladder cancer	0.000313	0.000635	CcSEcCtD
Telithromycin—Anorexia—Doxorubicin—urinary bladder cancer	0.000311	0.00063	CcSEcCtD
Telithromycin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00031	0.000629	CcSEcCtD
Telithromycin—Dyspepsia—Epirubicin—urinary bladder cancer	0.00031	0.000629	CcSEcCtD
Telithromycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000308	0.000625	CcSEcCtD
Telithromycin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000306	0.000621	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000305	0.00192	CbGpPWpGaD
Telithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000305	0.00192	CbGpPWpGaD
Telithromycin—Hypotension—Doxorubicin—urinary bladder cancer	0.000304	0.000618	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000304	0.000617	CcSEcCtD
Telithromycin—Fatigue—Epirubicin—urinary bladder cancer	0.000304	0.000616	CcSEcCtD
Telithromycin—Constipation—Epirubicin—urinary bladder cancer	0.000301	0.000611	CcSEcCtD
Telithromycin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000301	0.00189	CbGpPWpGaD
Telithromycin—Urticaria—Methotrexate—urinary bladder cancer	0.000299	0.000607	CcSEcCtD
Telithromycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000297	0.000604	CcSEcCtD
Telithromycin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000297	0.000603	CcSEcCtD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000297	0.00187	CbGpPWpGaD
Telithromycin—Insomnia—Doxorubicin—urinary bladder cancer	0.000295	0.000598	CcSEcCtD
Telithromycin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000293	0.000594	CcSEcCtD
Telithromycin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00029	0.000589	CcSEcCtD
Telithromycin—Somnolence—Doxorubicin—urinary bladder cancer	0.00029	0.000588	CcSEcCtD
Telithromycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000288	0.000585	CcSEcCtD
Telithromycin—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000288	0.00181	CbGpPWpGaD
Telithromycin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000287	0.000582	CcSEcCtD
Telithromycin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000283	0.000575	CcSEcCtD
Telithromycin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000281	0.000571	CcSEcCtD
Telithromycin—Fatigue—Doxorubicin—urinary bladder cancer	0.000281	0.00057	CcSEcCtD
Telithromycin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.00028	0.00176	CbGpPWpGaD
Telithromycin—Urticaria—Epirubicin—urinary bladder cancer	0.00028	0.000568	CcSEcCtD
Telithromycin—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000279	0.00176	CbGpPWpGaD
Telithromycin—Constipation—Doxorubicin—urinary bladder cancer	0.000279	0.000566	CcSEcCtD
Telithromycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000278	0.000565	CcSEcCtD
Telithromycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000277	0.000563	CcSEcCtD
Telithromycin—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000272	0.00171	CbGpPWpGaD
Telithromycin—Asthenia—Methotrexate—urinary bladder cancer	0.00027	0.000548	CcSEcCtD
Telithromycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000268	0.000545	CcSEcCtD
Telithromycin—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000268	0.00169	CbGpPWpGaD
Telithromycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000266	0.000541	CcSEcCtD
Telithromycin—Pruritus—Methotrexate—urinary bladder cancer	0.000266	0.00054	CcSEcCtD
Telithromycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000259	0.000527	CcSEcCtD
Telithromycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000259	0.000525	CcSEcCtD
Telithromycin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000258	0.000523	CcSEcCtD
Telithromycin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000257	0.000523	CcSEcCtD
Telithromycin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000257	0.00162	CbGpPWpGaD
Telithromycin—Asthenia—Epirubicin—urinary bladder cancer	0.000253	0.000513	CcSEcCtD
Telithromycin—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.00025	0.00157	CbGpPWpGaD
Telithromycin—Pruritus—Epirubicin—urinary bladder cancer	0.000249	0.000506	CcSEcCtD
Telithromycin—Dizziness—Methotrexate—urinary bladder cancer	0.000249	0.000505	CcSEcCtD
Telithromycin—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000246	0.00155	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000244	0.00154	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000244	0.00153	CbGpPWpGaD
Telithromycin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000241	0.000489	CcSEcCtD
Telithromycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00024	0.000487	CcSEcCtD
Telithromycin—Vomiting—Methotrexate—urinary bladder cancer	0.000239	0.000486	CcSEcCtD
Telithromycin—Rash—Methotrexate—urinary bladder cancer	0.000237	0.000482	CcSEcCtD
Telithromycin—Dermatitis—Methotrexate—urinary bladder cancer	0.000237	0.000481	CcSEcCtD
Telithromycin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000236	0.00149	CbGpPWpGaD
Telithromycin—Headache—Methotrexate—urinary bladder cancer	0.000236	0.000479	CcSEcCtD
Telithromycin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000235	0.00148	CbGpPWpGaD
Telithromycin—Asthenia—Doxorubicin—urinary bladder cancer	0.000234	0.000475	CcSEcCtD
Telithromycin—Dizziness—Epirubicin—urinary bladder cancer	0.000233	0.000473	CcSEcCtD
Telithromycin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000232	0.00146	CbGpPWpGaD
Telithromycin—Pruritus—Doxorubicin—urinary bladder cancer	0.000231	0.000468	CcSEcCtD
Telithromycin—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.00023	0.00145	CbGpPWpGaD
Telithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000228	0.00144	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000226	0.00142	CbGpPWpGaD
Telithromycin—Vomiting—Epirubicin—urinary bladder cancer	0.000224	0.000454	CcSEcCtD
Telithromycin—Nausea—Methotrexate—urinary bladder cancer	0.000224	0.000454	CcSEcCtD
Telithromycin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000223	0.000453	CcSEcCtD
Telithromycin—Rash—Epirubicin—urinary bladder cancer	0.000222	0.000451	CcSEcCtD
Telithromycin—Dermatitis—Epirubicin—urinary bladder cancer	0.000222	0.00045	CcSEcCtD
Telithromycin—Headache—Epirubicin—urinary bladder cancer	0.000221	0.000448	CcSEcCtD
Telithromycin—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000218	0.00138	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000218	0.00138	CbGpPWpGaD
Telithromycin—Dizziness—Doxorubicin—urinary bladder cancer	0.000215	0.000437	CcSEcCtD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000213	0.00134	CbGpPWpGaD
Telithromycin—Nausea—Epirubicin—urinary bladder cancer	0.000209	0.000425	CcSEcCtD
Telithromycin—Vomiting—Doxorubicin—urinary bladder cancer	0.000207	0.000421	CcSEcCtD
Telithromycin—Rash—Doxorubicin—urinary bladder cancer	0.000205	0.000417	CcSEcCtD
Telithromycin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000205	0.000417	CcSEcCtD
Telithromycin—Headache—Doxorubicin—urinary bladder cancer	0.000204	0.000414	CcSEcCtD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000203	0.00128	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000203	0.00128	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.0002	0.00126	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000197	0.00124	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000197	0.00124	CbGpPWpGaD
Telithromycin—Nausea—Doxorubicin—urinary bladder cancer	0.000194	0.000393	CcSEcCtD
Telithromycin—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000193	0.00122	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000191	0.0012	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000188	0.00118	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000182	0.00115	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.00018	0.00113	CbGpPWpGaD
Telithromycin—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000178	0.00112	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000177	0.00111	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000176	0.00111	CbGpPWpGaD
Telithromycin—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000175	0.0011	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000173	0.00109	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000173	0.00109	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.00017	0.00107	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000167	0.00105	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000166	0.00104	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000165	0.00104	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000165	0.00104	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000164	0.00103	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000163	0.00103	CbGpPWpGaD
Telithromycin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000162	0.00102	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000158	0.000995	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000158	0.000995	CbGpPWpGaD
Telithromycin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000151	0.000948	CbGpPWpGaD
Telithromycin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000148	0.000935	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000144	0.00091	CbGpPWpGaD
Telithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000139	0.000874	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000132	0.000834	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.00013	0.000819	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000126	0.000796	CbGpPWpGaD
Telithromycin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000125	0.000785	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.000123	0.000774	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.00012	0.000754	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.00012	0.000754	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000118	0.000746	CbGpPWpGaD
Telithromycin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000116	0.000732	CbGpPWpGaD
Telithromycin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000115	0.000722	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000112	0.000707	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000112	0.000707	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—RRM2—urinary bladder cancer	0.000103	0.000651	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000103	0.000647	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.0001	0.000632	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	9.57e-05	0.000603	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—ENO2—urinary bladder cancer	9.57e-05	0.000603	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	9.57e-05	0.000603	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	9.51e-05	0.000599	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	9.51e-05	0.000599	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.36e-05	0.000589	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	9.28e-05	0.000585	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	9.25e-05	0.000583	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	8.73e-05	0.00055	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	8.7e-05	0.000548	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	8.65e-05	0.000545	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	8.51e-05	0.000536	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	7.83e-05	0.000493	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.74e-05	0.000488	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	7.71e-05	0.000486	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	7.47e-05	0.000471	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	7.4e-05	0.000466	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.34e-05	0.000462	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.34e-05	0.000462	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	7.21e-05	0.000454	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	6.92e-05	0.000436	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	6.92e-05	0.000436	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.8e-05	0.000429	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.71e-05	0.000423	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	6.71e-05	0.000423	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	6.43e-05	0.000405	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	6.15e-05	0.000388	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.05e-05	0.000381	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	5.98e-05	0.000377	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	5.91e-05	0.000372	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	5.91e-05	0.000372	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.78e-05	0.000364	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	5.76e-05	0.000363	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.71e-05	0.00036	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	5.66e-05	0.000357	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.58e-05	0.000351	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.56e-05	0.000351	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	5.56e-05	0.00035	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.53e-05	0.000349	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.31e-05	0.000335	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	5.22e-05	0.000329	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	5.21e-05	0.000328	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.92e-05	0.00031	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.92e-05	0.00031	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.77e-05	0.000301	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.65e-05	0.000293	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	4.5e-05	0.000283	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.45e-05	0.00028	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.32e-05	0.000272	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.27e-05	0.000269	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.27e-05	0.000269	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.24e-05	0.000267	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	4.17e-05	0.000262	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	4.17e-05	0.000262	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.14e-05	0.000261	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.09e-05	0.000258	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.07e-05	0.000256	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	4.04e-05	0.000255	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.02e-05	0.000253	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.02e-05	0.000253	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.98e-05	0.000251	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.96e-05	0.00025	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	3.78e-05	0.000238	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.47e-05	0.000219	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	3.36e-05	0.000212	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.33e-05	0.00021	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.31e-05	0.000208	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.26e-05	0.000205	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.22e-05	0.000203	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.22e-05	0.000203	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.12e-05	0.000196	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.07e-05	0.000194	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.06e-05	0.000193	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.04e-05	0.000191	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.04e-05	0.000191	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.94e-05	0.000185	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.91e-05	0.000183	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.91e-05	0.000183	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.86e-05	0.00018	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.84e-05	0.000179	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.8e-05	0.000176	CbGpPWpGaD
Telithromycin—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.77e-05	0.000175	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.71e-05	0.000171	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.69e-05	0.000169	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.6e-05	0.000164	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.59e-05	0.000163	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.57e-05	0.000162	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.57e-05	0.000162	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.46e-05	0.000155	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.42e-05	0.000152	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.41e-05	0.000152	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.27e-05	0.000143	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.18e-05	0.000137	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.16e-05	0.000136	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.1e-05	0.000132	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.09e-05	0.000132	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.01e-05	0.000127	CbGpPWpGaD
Telithromycin—CYP3A5—Metabolism—EP300—urinary bladder cancer	2e-05	0.000126	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.99e-05	0.000125	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.99e-05	0.000125	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.9e-05	0.00012	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.87e-05	0.000118	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.84e-05	0.000116	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	0.000112	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.76e-05	0.000111	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.71e-05	0.000108	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.49e-05	9.41e-05	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	9.14e-05	CbGpPWpGaD
Telithromycin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.42e-05	8.98e-05	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.42e-05	8.97e-05	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.37e-05	8.62e-05	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.27e-05	7.97e-05	CbGpPWpGaD
Telithromycin—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.21e-05	7.6e-05	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.12e-05	7.06e-05	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.77e-06	6.15e-05	CbGpPWpGaD
Telithromycin—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.31e-06	5.87e-05	CbGpPWpGaD
